Kazia Therapeutics (KZIA) Competitors $0.88 +0.00 (+0.11%) Closing price 02/21/2025 03:57 PM EasternExtended Trading$0.87 -0.01 (-1.14%) As of 02/21/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends KZIA vs. GELS, MTEX, LIAN, NXTC, LPTX, INAB, APRE, OKUR, SNTI, and MIRAShould you be buying Kazia Therapeutics stock or one of its competitors? The main competitors of Kazia Therapeutics include Gelteq (GELS), Mannatech (MTEX), LianBio (LIAN), NextCure (NXTC), Leap Therapeutics (LPTX), IN8bio (INAB), Aprea Therapeutics (APRE), OnKure Therapeutics (OKUR), Senti Biosciences (SNTI), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "pharmaceutical products" industry. Kazia Therapeutics vs. Gelteq Mannatech LianBio NextCure Leap Therapeutics IN8bio Aprea Therapeutics OnKure Therapeutics Senti Biosciences MIRA Pharmaceuticals Kazia Therapeutics (NASDAQ:KZIA) and Gelteq (NASDAQ:GELS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking. Does the media favor KZIA or GELS? In the previous week, Kazia Therapeutics had 1 more articles in the media than Gelteq. MarketBeat recorded 1 mentions for Kazia Therapeutics and 0 mentions for Gelteq. Kazia Therapeutics' average media sentiment score of 1.27 beat Gelteq's score of 0.00 indicating that Kazia Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Kazia Therapeutics Positive Gelteq Neutral Does the MarketBeat Community prefer KZIA or GELS? Kazia Therapeutics received 80 more outperform votes than Gelteq when rated by MarketBeat users. CompanyUnderperformOutperformKazia TherapeuticsOutperform Votes8052.98% Underperform Votes7147.02% GelteqN/AN/A Which has better earnings & valuation, KZIA or GELS? Gelteq has lower revenue, but higher earnings than Kazia Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKazia Therapeutics$1.51M2.94-$17.56MN/AN/AGelteqN/AN/AN/AN/AN/A Do analysts rate KZIA or GELS? Kazia Therapeutics currently has a consensus target price of $11.50, suggesting a potential upside of 1,206.82%. Given Kazia Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Kazia Therapeutics is more favorable than Gelteq.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kazia Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Gelteq 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in KZIA or GELS? 30.9% of Kazia Therapeutics shares are held by institutional investors. 1.0% of Kazia Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is KZIA or GELS more profitable? Company Net Margins Return on Equity Return on Assets Kazia TherapeuticsN/A N/A N/A Gelteq N/A N/A N/A SummaryKazia Therapeutics beats Gelteq on 9 of the 9 factors compared between the two stocks. Get Kazia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KZIA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KZIA vs. The Competition Export to ExcelMetricKazia TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.43M$7.06B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A5.8226.1519.13Price / Sales2.94268.05435.3370.72Price / CashN/A65.6738.0134.83Price / Book-0.456.717.644.62Net Income-$17.56M$138.55M$3.19B$245.94M7 Day Performance-1.12%-2.63%-2.11%-2.62%1 Month Performance-35.77%-2.33%-0.49%-2.15%1 Year Performance-70.62%-5.33%16.44%12.95% Kazia Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KZIAKazia Therapeutics3.2279 of 5 stars$0.88+0.1%$11.50+1,206.8%-72.1%$4.43M$1.51M0.0012Upcoming EarningsPositive NewsGELSGelteqN/A$2.24-2.2%N/AN/A$21.15MN/A0.00N/AGap UpMTEXMannatech0.5397 of 5 stars$11.20-1.8%N/A+27.8%$21.11M$121.55M-13.83250Analyst ForecastGap UpLIANLianBioN/A$0.19flatN/A-95.7%$20.88MN/A-0.24110News CoverageGap DownNXTCNextCure4.0633 of 5 stars$0.74-2.8%$4.00+441.6%-55.9%$20.69MN/A-0.3590Gap UpLPTXLeap Therapeutics1.3579 of 5 stars$0.54+5.6%$4.92+814.7%-84.0%$20.60MN/A-0.2840INABIN8bio3.7434 of 5 stars$0.27+3.9%$7.75+2,769.3%-73.6%$19.58MN/A-0.3620Gap DownAPREAprea Therapeutics2.1246 of 5 stars$3.59-6.3%$15.50+331.8%-58.3%$19.49M$580,000.00-1.287OKUROnKure Therapeutics2.6327 of 5 stars$5.82-0.5%$36.00+518.6%N/A$19.44MN/A-0.48N/AGap UpSNTISenti Biosciences2.3763 of 5 stars$4.02-3.1%$10.00+148.8%-5.3%$19.38M$2.56M-0.264MIRAMIRA Pharmaceuticals2.1128 of 5 stars$1.17+1.7%$14.00+1,096.6%+1.9%$19.38MN/A-2.092 Related Companies and Tools Related Companies GELS Alternatives MTEX Alternatives LIAN Alternatives NXTC Alternatives LPTX Alternatives INAB Alternatives APRE Alternatives OKUR Alternatives SNTI Alternatives MIRA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KZIA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KZIA Stock Alerts